View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
May 17, 2021

Why Russia and China shouldn’t be ignored when Covid vaccines are discussed

By Paul Dennis

17 May

Dean Baker, senior economist at the Centre for Economic and Policy Research (CEPR), retweeted on a New York Times (NYT) piece on vaccinating the world that completely ignored the vaccines developed by China and Russia.

Experts believe that both of the countries have developed effective vaccines against the coronavirus, which have slowed the spread and reduced hospitalisations and deaths.

Therefore, it was imperative to consider the production of their vaccines while discussing world immunisation against the virus.

The second point the article misses, experts opine, is the need for open-source technologies.

The idea is not just to replicate the technology of Pfizer or Moderna Covid-19 vaccines, but to allow engineers to examine it, and improve it.

Similar efforts with the production technology for shortage of inputs is required, along with the cooperation of Chinese and Russian vaccine manufacturers as well.

Economists believe that the technology for producing all Covid-19 vaccines should be open-sourced to get the world vaccinated at a faster pace.

Read more

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology